TB - Nursing Case Study

Pathophysiology

• Primary mechanism: Mycobacterium tuberculosis, the causative agent of TB, is inhaled and reaches the alveoli, where it is engulfed by macrophages. However, it can survive and replicate within these cells due to its waxy cell wall, leading to a latent infection.

• Secondary mechanism: The immune system forms granulomas to contain the bacteria. In some cases, these granulomas break down, especially in immunocompromised individuals, leading to active TB where the bacteria spread and cause tissue destruction.

• Key complication: If active TB is not treated, it can lead to pulmonary damage, cavitation, and disseminated disease, affecting other organs and causing severe systemic symptoms.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: History of smoking for 20 years, hypertension

• Current medications: Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and weight loss

• Key symptoms: Night sweats, fever, fatigue, chest pain

• Vital signs: Temperature: 101.3°F, Heart rate: 110 bpm, Respiratory rate: 24 breaths/min, Blood pressure: 140/90 mmHg, Oxygen saturation: 92% on room air

Section 1

Following the initial presentation, the patient underwent a series of diagnostic evaluations to confirm the presence of active tuberculosis and assess the extent of the disease. A chest X-ray revealed a cavitary lesion in the right upper lobe, consistent with pulmonary tuberculosis. Sputum samples were collected and tested positive for acid-fast bacilli, confirming the active TB diagnosis. Additionally, a CT scan of the chest showed multiple areas of consolidation and lymphadenopathy, suggesting possible extrapulmonary involvement.

Despite starting the standard antitubercular therapy regimen, comprising isoniazid, rifampin, ethambutol, and pyrazinamide, the patient exhibited a change in clinical status. Over the next few days, his respiratory distress worsened, and he developed hemoptysis. His oxygen saturation decreased to 88% on room air, necessitating supplemental oxygen. Laboratory tests indicated a rising white blood cell count, suggestive of a secondary bacterial infection. A bronchoscopy was performed, revealing significant endobronchial inflammation and confirming a superimposed bacterial pneumonia, a common complication in patients with cavitary TB lesions.

This new development requires careful clinical reasoning to adjust the treatment plan. The addition of broad-spectrum antibiotics was necessary to address the bacterial pneumonia, while close monitoring of liver function tests was imperative due to the potential hepatotoxicity of the TB medications in conjunction with the new antibiotics. The patient's smoking history and hypertension may also complicate the management of his respiratory and cardiovascular status, highlighting the need for multidisciplinary care to optimize his recovery and prevent further complications.

Section 2

In the days following the adjustment of the treatment plan to include broad-spectrum antibiotics, the patient's condition initially showed signs of stabilization. His oxygen saturation improved to 92% with supplemental oxygen via nasal cannula, and his respiratory rate decreased to 22 breaths per minute. However, the patient's blood pressure remained intermittently elevated at 150/95 mmHg, necessitating careful titration of antihypertensive medication. Despite these improvements, his hemoptysis persisted, albeit less frequently, and his white blood cell count remained elevated at 14,000/mm³, indicating a persistent inflammatory response.

Further laboratory tests revealed a concerning rise in liver enzymes, with AST and ALT levels reaching 120 U/L and 130 U/L, respectively, raising alarms about potential hepatotoxicity. These findings prompted a reevaluation of his medication regimen, considering the hepatotoxic nature of both the TB medications and the newly introduced antibiotics. The healthcare team decided to temporarily withhold pyrazinamide, one of the TB drugs most commonly associated with liver toxicity, while closely monitoring liver function tests and adjusting antibiotic therapy as necessary.

Clinically, the patient reported increased fatigue and mild confusion, prompting a neurological assessment that revealed subtle cognitive changes. This development necessitated a brain MRI to rule out possible TB meningitis or other central nervous system involvement, given the patient's history of extrapulmonary TB. The nursing team focused on educating the patient and his family about the importance of medication adherence and the need for regular monitoring of his condition to prevent further complications. This collaborative approach aimed to optimize the patient's recovery trajectory while addressing the multifaceted challenges of managing active TB with concurrent bacterial infection and potential medication-related side effects.

Section 3

In the subsequent days, the patient's condition exhibited subtle yet notable changes, warranting careful monitoring by the healthcare team. Despite the temporary withholding of pyrazinamide, the patient's liver enzyme levels continued to rise, with AST increasing to 135 U/L and ALT to 145 U/L. Concurrently, the patient's bilirubin levels showed a slight elevation, reaching 2.0 mg/dL. These laboratory findings suggested that the hepatotoxicity might be exacerbated by the broad-spectrum antibiotics, prompting the team to reconsider the antibiotic regimen and explore alternative medications with a lower risk of liver toxicity.

In addition to hepatic concerns, the patient's respiratory status presented new challenges. His oxygen saturation began to fluctuate between 88-90% despite supplemental oxygen, and he developed a mild wheeze upon auscultation. These respiratory changes, coupled with a persistent, dry cough, raised suspicions about potential airway hyperreactivity or an emerging secondary infection. A chest X-ray was ordered, revealing patchy infiltrates in the lower lobes, suggestive of either a bacterial superinfection or worsening of the TB infection. This necessitated a further revision of the treatment plan, balancing the need to address the possible new infection while minimizing additional hepatic strain.

The patient's neurological status also evolved, with episodes of mild confusion becoming more frequent. Although the brain MRI ruled out TB meningitis, the team noted slight cerebral atrophy, which, combined with the patient's metabolic derangements, could be contributing to his cognitive symptoms. This finding led to an interdisciplinary approach involving neurology and hepatology consultations to address both the neurological and hepatic complications. The nursing team continued to emphasize the importance of nutritional support, hydration, and medication adherence, while preparing the patient and his family for potential adjustments in the therapeutic approach. This proactive strategy aimed to stabilize the patient's condition and prevent further complications, ensuring a comprehensive approach to his complex care needs.

Section 4

In the days following the revised treatment plan, the healthcare team closely monitored the patient's response to the interventions. A significant change in the patient's status became apparent as he developed a low-grade fever of 100.4°F, accompanied by increased fatigue and a worsening cough. His oxygen saturation dropped further to 85% on room air, prompting an escalation in supplemental oxygen delivery. The patient's respiratory rate increased to 24 breaths per minute, and auscultation revealed more pronounced wheezing and crackles in the lower lobes, suggesting possible progression of the pulmonary condition. Despite these respiratory challenges, the patient's blood pressure remained stable at 118/76 mmHg, and his heart rate was slightly elevated at 102 beats per minute.

Laboratory results showed a continued upward trend in liver enzymes, with AST rising to 150 U/L and ALT to 160 U/L, while bilirubin remained stable at 2.0 mg/dL. These findings raised concerns about the ongoing hepatotoxic effects of the medications, necessitating further adjustments to the treatment regimen. The team opted to switch the broad-spectrum antibiotics to a less hepatotoxic alternative, while continuing to manage the TB infection with caution. The patient's renal function markers, including BUN and creatinine levels, remained within normal limits, indicating no renal impairment at this stage.

The patient's neurological status also demanded attention, as episodes of confusion persisted, particularly in the evenings. With the interdisciplinary team actively involved, neurology suggested a trial of low-dose corticosteroids to address potential cerebral edema or inflammation, while continuing metabolic support to optimize cognitive function. The nursing team played a crucial role in implementing these changes, ensuring close monitoring for any adverse effects and reinforcing patient education on the importance of medication adherence and lifestyle modifications. The focus remained on comprehensive care, aiming to stabilize the patient's condition and prevent further deterioration, while preparing for potential adjustments based on his evolving clinical picture.

Section 5

As the healthcare team continued to monitor the patient, his condition exhibited further complications that demanded immediate attention. On the third day of the revised treatment plan, the patient experienced a sudden increase in his respiratory distress. His oxygen saturation dropped to 80% despite receiving supplemental oxygen at 6 L/min via nasal cannula. His respiratory rate surged to 30 breaths per minute, and he appeared visibly anxious, using accessory muscles to breathe. Auscultation revealed diminished breath sounds in the right lower lobe, raising suspicion of a possible pleural effusion or pneumothorax. In response to these alarming signs, the team swiftly escalated his care, transitioning him to a non-rebreather mask to improve his oxygenation while preparing for an urgent chest X-ray to elucidate the underlying cause of his deteriorating respiratory status.

The chest X-ray confirmed the presence of a moderate right-sided pleural effusion, which likely contributed to the patient's increased respiratory distress. Given the new findings, the decision was made to perform a therapeutic thoracentesis to relieve the pressure on his lungs and improve his breathing. The procedure was performed successfully, yielding 800 mL of straw-colored fluid, which was sent for analysis to rule out infection or malignant processes. Following the thoracentesis, the patient's respiratory status improved notably; his oxygen saturation increased to 92% on 4 L/min of oxygen, and his respiratory rate decreased to 22 breaths per minute. Despite the temporary relief, the team remained vigilant, recognizing that the pleural effusion could recur or signal a more complex underlying issue, necessitating ongoing assessment and potential further interventions.

In parallel, the patient's neurological status remained a concern, as his episodes of confusion persisted, albeit with slight improvement following the initiation of low-dose corticosteroids. However, the team noted new onset tremors and mild asterixis, prompting a review of his medication regimen and potential drug interactions. Given the elevated liver enzymes, hepatotoxicity from TB medications was reconsidered, and the team initiated discussions on potential alternative treatments to balance effective TB management with minimizing adverse effects. This necessitated a delicate approach, weighing the risks and benefits of modifying the current regimen while ensuring the patient's overall stabilization. The interdisciplinary team's commitment to comprehensive and dynamic care planning continued to be vital, as they worked collaboratively to navigate the intricacies of the patient's evolving clinical picture.